In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera’s FDA IND approval to Brexogen’s recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.

The Exosome Characterization & Analytical Development Summit offers a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes.

Across three days in April, this hotly anticipated summit will unite key experts from AbbVie, Aegle Therapeutics, Vesigen Therapeutics, and more to unite an industry on:

• In depth technical content of exosome analysis and parameters for confidence in quality
• Defining standardized tools and techniques while keeping regulatory guidance in mind for clinical progression
• Bridging communications and networking between Analytical Experts and Decision Makers

To learn more, and secure your place, check out the official event website here: https://ter.li/v1xubp

Download the full event guide here: https://ter.li/182ula